---
title: bit.bio | The story of bit.bio by CEO Dr Mark Kotter | Healthtech Podcast
description: The conversation covers the promise of reprogrammed human cells for therapies and drug discovery.
---

[News | bit.bio ](https://www.bit.bio/news)

# [bit.bio | The story of bit.bio by CEO Dr Mark Kotter | Healthtech Podcast](https://www.bit.bio/news/the-story-of-bit-bio-on-the-healthtech-podcast)

 Written by [Healthtech podcast](https://www.bit.bio/news/author/healthtech-podcast) | Jun 9, 2021 11:00:00 PM

 bit.bio CEO and Founder Mark Kotter was interviewed on the Healthtech podcast. In this  
episode he talks to host James Somauroo about his journey to founding the company, how our [opti-ox](https://www-bit-bio.sandbox.hs-sites.com/platform)™ technology was discovered, what bit.bio hopes to do with human cells and how we’re also supporting Meatable with opti-ox™ to create cultured meat.

[Listen here or below](https://anchor.fm/healthtech/episodes/204-The-Story-of-Bit-Bio-with-CEO-Dr-Mark-Kotter-eu0tvl)

 

[View full post](https://www.bit.bio/news/the-story-of-bit-bio-on-the-healthtech-podcast)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Healthtech podcast"
  },
  "dateModified" : "2022-10-29T08:05:51.596Z",
  "datePublished" : "2021-06-09T23:00:00Z",
  "headline" : "The story of bit.bio on the Healthtech Podcast",
  "image" : {
    "@type" : "ImageObject",
    "height" : 755,
    "url" : "https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Imported_Blog_Media/blog-healthtech-podcast-new.jpg",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://www.bit.bio/news/the-story-of-bit-bio-on-the-healthtech-podcast",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```